Who owns Antigenics?

Key details on Antigenics (Ticker: AGEN)

Who owns Antigenics?

Is AGEN a good stock to own? Find out who bought Antigenics, who sold Antigenics (AGEN) stock, and who holds a large position in Antigenics.

Fund Name Number of Shares Share Valuation As Of

Who sold Antigenics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Burns Wealth Management March 31, 2013 67 $0
Bruce & Co Sept. 30, 2011 1.40M $658516
Oracle Investment Management Dec. 31, 2010 3.62M $3.66M
FMR Dec. 31, 2010 393200 $393200
Wells Fargo & Company Dec. 31, 2010 338285 $338285
Geode Capital Management Dec. 31, 2010 220982 $220982
T. Rowe Price Associates Dec. 31, 2010 61400 $60786
Knight Capital Dec. 31, 2010 32179 $33144
CITADEL ADVISORS Dec. 31, 2010 14665 $14958
UBS AG Dec. 31, 2010 12621 $12747
RHUMBLINE ADVISERS Dec. 31, 2007 11100 $22977
Manulife Asset Management Dec. 31, 2007 1244 $2998
Public Employees' Retirement Association of Colorado Sept. 30, 2006 29700 $46035
Manufacturers Life Insurance Company Sept. 30, 2003 44921 $548036
Tudor Investment Corporation Dec. 31, 2000 17500 $194075